医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

ニュース
添付文書
薬の臨床実感＆助言集

その他

eCargo and McPherson’s Forge Distribution Partnership to Grow A’kin Product Line in China

eCargo and McPherson’s Forge Distribution Partnership to Grow A’kin Product Line in China

その他ヘルスヘルスケアヘルス一般　 TimeLine: eCargo and McPherson’s Forge Distribution Partnership to Grow A’kin Product Line in China

2023年02月02日

TURALIO® New Dosing Regimen Now Available in the U.S. for Certain Patients with Tenosynovial Giant Cell Tumor

TURALIO® New Dosing Regimen Now Available in the U.S. for Certain Patients with Tenosynovial Giant Cell Tumor

バイオテクノロジーヘルスケアヘルス一般腫瘍学製薬　 TimeLine: for Certain Patients with Tenosynovial Giant Cell Tumor New Dosing TURALIO

2023年02月01日

Ronovo Surgical Emerges with $50M+ to Accelerate Paradigm Shift Towards Intelligent Robotic Laparoscopy

バイオテクノロジーヘルスケアヘルス一般外科　 TimeLine: $50M+ to Accelerate Paradigm Shift Towards Intelligent Robotic Laparoscopy Ronovo Surgical Emerges with

2023年02月01日

With New Vertical, Innova Solutions Focuses on Advancing Innovation in Healthcare ＆ Life Sciences

With New Vertical, Innova Solutions Focuses on Advancing Innovation in Healthcare ＆ Life Sciences

その他ヘルスヘルスケアマネージド・ケア病院臨床試験　 TimeLine: Innova Solutions Focuses on Advancing Innovation in Healthcare Life Sciences With New Vertical

2023年02月01日

NOX, a Global Leader in Flooring, Introduces Bio-Circular Balanced PVC to its Entire Products for the First Time in the World

NOX, a Global Leader in Flooring, Introduces Bio-Circular Balanced PVC to its Entire Products for the First Time in the World

ヘルスケアヘルス一般　 TimeLine: NOX

2023年02月01日

New Promega Chemistry Will Enable Forensic DNA Labs to Solve More Challenging Cold Cases, Sexual Assault Cases

New Promega Chemistry Will Enable Forensic DNA Labs to Solve More Challenging Cold Cases, Sexual Assault Cases

その他ヘルスバイオテクノロジーヘルスケア臨床試験製薬遺伝学　 TimeLine: New Promega Chemistry Will Enable Forensic DNA Labs to Solve More Challenging Cold Cases Sexual Assault Cases

2023年01月31日

Qurient Announces Dosing of First Patient in Q702 in Combination with KEYTRUDA® in a Phase 1b/2 Clinical Study for the Treatment of Patients with Solid Tumors

Qurient Announces Dosing of First Patient in Q702 in Combination with KEYTRUDA® in a Phase 1b/2 Clinical Study for the Treatment of Patients with Solid Tumors

ヘルスケアヘルス一般腫瘍学臨床試験製薬　 TimeLine: Clinical Study for the Treatment of Patients with Solid Tumors in a Phase 1b of First Patient in Q702 in Combination with KEYTRUDA Qurient Announces Dosing

2023年01月31日

Carbios在产业和商业发展的关键年份加强执行委员会

Carbios在产业和商业发展的关键年份加强执行委员会

その他ヘルスバイオテクノロジーヘルスケア　 TimeLine: Carbios在产业和商业发展的关键年份加强执行委员会

2023年01月30日

Philip Morris International Inc. (PMI) Announces Agreement to Extend and Deepen Collaboration With KT＆G

Philip Morris International Inc. (PMI) Announces Agreement to Extend and Deepen Collaboration With KT＆G

ヘルスケアヘルス一般　 TimeLine: Announces Agreement to Extend and Deepen Collaboration With KT＆G Philip Morris International Inc PMI

2023年01月30日

武田获得和黄医药的高选择性口服VEGFR1/2/3酪氨酸激酶抑制剂呋喹替尼的全球（中国以外）独家授权

武田获得和黄医药的高选择性口服VEGFR1/2/3酪氨酸激酶抑制剂呋喹替尼的全球（中国以外）独家授权

その他ヘルスバイオテクノロジーヘルスケアヘルス一般腫瘍学製薬　 TimeLine: 武田获得和黄医独家授权酸激酶抑制剂呋喹替尼的全球高选择性口服VEGFR

2023年01月30日